Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data

BACKGROUND: After progression to a standard first-line platinum and gemcitabine combination (GP), there is no established second-line therapy for patients with advanced biliary tract cancers (aBTC). Indeed, literature data suggest limited activity of most second-line agents evaluated so far. METHODS...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Exp Clin Cancer Res
Asıl Yazarlar: Fornaro, Lorenzo, Vivaldi, Caterina, Cereda, Stefano, Leone, Francesco, Aprile, Giuseppe, Lonardi, Sara, Silvestris, Nicola, Santini, Daniele, Milella, Michele, Caparello, Chiara, Musettini, Gianna, Pasquini, Giulia, Falcone, Alfredo, Brandi, Giovanni, Sperduti, Isabella, Vasile, Enrico
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4689003/
https://ncbi.nlm.nih.gov/pubmed/26693938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-015-0267-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller